Showing results (11-20 of 92) with videos related to

Sort By:
Pageof 10
Clinical Nutrition ESPEN|February 21, 2018
Zùsto: A new sweetening agent with low glycemic indexJoeri Jan Pen, Galina Khorosheva, Ursule Van de Velde, et al.
Diabetes/Metabolism Research and Reviews|November 10, 2011
Preservation of recall immunity in anti-CD3-treated recent onset type 1 diabetes patientsGonnie M Alkemade, Robert Hilbrands, Evy Vandemeulebroucke, et al.
Journal of Vascular and Interventional Radiology : JVIR|December 24, 2005
Feasibility, safety, and efficacy of percutaneous transhepatic injection of beta-cell graftsGeert Maleux, Pieter Gillard, Bart Keymeulen, et al.
Annals of Vascular Surgery|April 26, 2011
The ankle--brachial index and the diabetic foot: a troublesome marriageDimitri Aerden, Dany Massaad, Karl von Kemp, et al.
Transplantation|February 10, 2009
Functional beta-cell mass and insulin sensitivity is decreased in insulin-independent pancreas-kidney recipientsPieter Gillard, Evy Vandemeulebroucke, Bart Keymeulen, et al.
Transplantation|January 24, 2008
Comparison of sirolimus alone with sirolimus plus tacrolimus in type 1 diabetic recipients of cultured islet cell graftsPieter Gillard, Zhidong Ling, Chantal Mathieu, et al.
Plos One|May 3, 2021
Lower beta cell yield from donor pancreases after controlled circulatory death prevented by shortening acirculatory warm ischemia time and by using IGL-1 cold preservation solutionDiedert L De Paep, Freya Van Hulle, Zhidong Ling, et al.
Diabetes|April 6, 2013
Potential of protein phosphatase inhibitor 1 as biomarker of pancreatic β-cell injury in vitro and in vivoLei Jiang, Benedicte Brackeva, Zhidong Ling, et al.
Diabetes Care|July 6, 2026
The Correlation Between Fear and Perceived Frequency of Hypoglycemia and Continuous Glucose Monitoring Metrics in Adults With Type 1 Diabetes Using Diabetes Technology: A One-Year AnalysisLaura Valgaerts, Jolien De Meulemeester, Margaretha M Visser, et al.
Diabetes Care|June 25, 2009
Graves hyperthyroidism after stopping immunosuppressive therapy in type 1 diabetic Islet cell recipients with pretransplant TPO autoantibodiesPieter Gillard, Volkert Huurman, Bart Van der Auwera, et al.
Pageof 10